Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway

Pulmonary fibrosis is a progressive and fatal lung disorder with high mortality rate. To date, despite the fact that extensive research trials are ongoing, pulmonary fibrosis continues to have a poor response to available medical therapy. Statins, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Bo, Ma, Ai-Qun, Yang, Lan, Dang, Xiao-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876122/
https://www.ncbi.nlm.nih.gov/pubmed/24351828
http://dx.doi.org/10.3390/ijms141224476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876122/
https://www.ncbi.nlm.nih.gov/pubmed/24351828
http://dx.doi.org/10.3390/ijms141224476

Ejemplares similares